| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 21 | 2022 | 30 | 3.830 |
Why?
|
| Neuroblastoma | 8 | 2025 | 550 | 3.350 |
Why?
|
| Adipocytes | 15 | 2020 | 178 | 2.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2025 | 2057 | 1.790 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 240 | 1.700 |
Why?
|
| Trans-Activators | 8 | 2021 | 712 | 1.530 |
Why?
|
| Cell Line, Tumor | 23 | 2025 | 3681 | 1.420 |
Why?
|
| Disease Progression | 9 | 2025 | 2225 | 1.300 |
Why?
|
| Immunotherapy | 7 | 2025 | 745 | 1.240 |
Why?
|
| Stomach Neoplasms | 5 | 2025 | 566 | 1.230 |
Why?
|
| Imidazoles | 3 | 2025 | 219 | 1.200 |
Why?
|
| YY1 Transcription Factor | 2 | 2024 | 18 | 1.060 |
Why?
|
| Cell Line | 15 | 2023 | 2719 | 1.050 |
Why?
|
| ELAV-Like Protein 1 | 3 | 2025 | 11 | 1.040 |
Why?
|
| Mice | 58 | 2025 | 18466 | 0.990 |
Why?
|
| RNA-Binding Proteins | 5 | 2025 | 604 | 0.980 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2021 | 613 | 0.970 |
Why?
|
| Forkhead Transcription Factors | 7 | 2017 | 381 | 0.950 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2024 | 26 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 16 | 2025 | 4754 | 0.850 |
Why?
|
| Nanoparticles | 6 | 2025 | 290 | 0.850 |
Why?
|
| Tumor Microenvironment | 4 | 2025 | 688 | 0.840 |
Why?
|
| Cell Differentiation | 12 | 2020 | 1960 | 0.830 |
Why?
|
| Mitochondria | 12 | 2021 | 747 | 0.820 |
Why?
|
| Sirtuins | 5 | 2011 | 20 | 0.810 |
Why?
|
| RNA, Messenger | 9 | 2024 | 2674 | 0.810 |
Why?
|
| Animals | 67 | 2025 | 34798 | 0.800 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 207 | 0.780 |
Why?
|
| Lymph Nodes | 1 | 2024 | 389 | 0.760 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2020 | 294 | 0.760 |
Why?
|
| Transcription Factors | 14 | 2023 | 2493 | 0.760 |
Why?
|
| Gluconeogenesis | 2 | 2022 | 96 | 0.750 |
Why?
|
| Up-Regulation | 6 | 2020 | 876 | 0.750 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 50 | 0.740 |
Why?
|
| Sirtuin 2 | 5 | 2017 | 11 | 0.740 |
Why?
|
| Adipose Tissue, Brown | 7 | 2019 | 87 | 0.730 |
Why?
|
| Histones | 3 | 2023 | 534 | 0.680 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2020 | 8 | 0.660 |
Why?
|
| CCCTC-Binding Factor | 1 | 2020 | 19 | 0.650 |
Why?
|
| Promoter Regions, Genetic | 10 | 2024 | 1280 | 0.630 |
Why?
|
| Glioblastoma | 1 | 2023 | 363 | 0.630 |
Why?
|
| Acetylation | 11 | 2023 | 191 | 0.620 |
Why?
|
| Glycolysis | 1 | 2020 | 166 | 0.610 |
Why?
|
| DNA-Binding Proteins | 7 | 2023 | 1977 | 0.610 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 169 | 0.610 |
Why?
|
| Oxidative Stress | 5 | 2022 | 803 | 0.600 |
Why?
|
| Hepatocytes | 5 | 2022 | 237 | 0.590 |
Why?
|
| GATA2 Transcription Factor | 8 | 2023 | 46 | 0.590 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 146 | 0.590 |
Why?
|
| Transcriptional Activation | 5 | 2024 | 429 | 0.580 |
Why?
|
| beta Catenin | 1 | 2020 | 225 | 0.570 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2020 | 175 | 0.550 |
Why?
|
| Macrophages | 5 | 2025 | 689 | 0.530 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 396 | 0.520 |
Why?
|
| Protein Binding | 10 | 2024 | 1730 | 0.520 |
Why?
|
| Reactive Oxygen Species | 7 | 2021 | 517 | 0.500 |
Why?
|
| Sirtuin 1 | 4 | 2021 | 54 | 0.500 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2508 | 0.470 |
Why?
|
| Insulin Resistance | 4 | 2021 | 698 | 0.460 |
Why?
|
| Caloric Restriction | 4 | 2010 | 97 | 0.460 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 729 | 0.450 |
Why?
|
| Humans | 58 | 2025 | 132089 | 0.450 |
Why?
|
| Adipose Tissue | 6 | 2021 | 504 | 0.440 |
Why?
|
| Malates | 2 | 2024 | 8 | 0.430 |
Why?
|
| Mitochondrial Proteins | 7 | 2022 | 260 | 0.420 |
Why?
|
| Aspartic Acid | 2 | 2024 | 84 | 0.410 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2011 | 251 | 0.410 |
Why?
|
| GATA3 Transcription Factor | 4 | 2007 | 42 | 0.410 |
Why?
|
| Signal Transduction | 14 | 2025 | 4704 | 0.410 |
Why?
|
| PPAR gamma | 3 | 2019 | 88 | 0.380 |
Why?
|
| Adipogenesis | 5 | 2020 | 80 | 0.380 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 43 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 5 | 2024 | 1046 | 0.360 |
Why?
|
| Multiple Myeloma | 3 | 2020 | 204 | 0.360 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2011 | 20 | 0.360 |
Why?
|
| Adipose Tissue, White | 2 | 2011 | 94 | 0.350 |
Why?
|
| HEK293 Cells | 7 | 2020 | 799 | 0.350 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 1035 | 0.350 |
Why?
|
| Dendrimers | 3 | 2025 | 10 | 0.340 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1336 | 0.330 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1278 | 0.330 |
Why?
|
| Autophagy | 4 | 2022 | 426 | 0.330 |
Why?
|
| Proteins | 5 | 2010 | 1035 | 0.320 |
Why?
|
| Lipolysis | 3 | 2019 | 75 | 0.310 |
Why?
|
| Body Composition | 3 | 2019 | 550 | 0.300 |
Why?
|
| Heterografts | 2 | 2020 | 197 | 0.300 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2008 | 14 | 0.300 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 122 | 0.290 |
Why?
|
| Cytokines | 2 | 2012 | 1359 | 0.290 |
Why?
|
| Physical Conditioning, Animal | 1 | 2009 | 85 | 0.290 |
Why?
|
| Adiponectin | 2 | 2006 | 128 | 0.290 |
Why?
|
| Thermogenesis | 3 | 2019 | 51 | 0.280 |
Why?
|
| Neoplasms | 4 | 2025 | 2957 | 0.280 |
Why?
|
| RNA, Small Interfering | 4 | 2022 | 687 | 0.270 |
Why?
|
| Doxorubicin | 2 | 2022 | 303 | 0.270 |
Why?
|
| Lipid Metabolism | 5 | 2023 | 381 | 0.270 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 110 | 0.260 |
Why?
|
| Aging | 3 | 2011 | 1248 | 0.260 |
Why?
|
| Mice, Obese | 2 | 2022 | 76 | 0.260 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2017 | 97 | 0.260 |
Why?
|
| Polyethylene Glycols | 2 | 2025 | 251 | 0.250 |
Why?
|
| Phagocytosis | 2 | 2025 | 191 | 0.250 |
Why?
|
| Mammary Glands, Human | 1 | 2007 | 81 | 0.250 |
Why?
|
| 3T3 Cells | 5 | 2020 | 124 | 0.240 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 1998 | 147 | 0.240 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2025 | 2 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2023 | 917 | 0.240 |
Why?
|
| Repressor Proteins | 2 | 2008 | 812 | 0.230 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 10 | 0.230 |
Why?
|
| Uncoupling Protein 1 | 3 | 2019 | 32 | 0.230 |
Why?
|
| Mice, Nude | 3 | 2025 | 751 | 0.230 |
Why?
|
| Cell Lineage | 1 | 2007 | 357 | 0.230 |
Why?
|
| RNA, Small Nucleolar | 1 | 2025 | 15 | 0.230 |
Why?
|
| Dendritic Cells | 2 | 2025 | 448 | 0.230 |
Why?
|
| Hyaluronan Receptors | 1 | 2025 | 62 | 0.220 |
Why?
|
| Models, Biological | 2 | 2020 | 1443 | 0.220 |
Why?
|
| Mice, Knockout | 12 | 2021 | 3861 | 0.220 |
Why?
|
| Particle Size | 1 | 2024 | 149 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 397 | 0.220 |
Why?
|
| RNA Interference | 3 | 2019 | 514 | 0.210 |
Why?
|
| Alternative Splicing | 2 | 2025 | 363 | 0.210 |
Why?
|
| Prodrugs | 1 | 2024 | 62 | 0.210 |
Why?
|
| RNA, Transfer | 1 | 2024 | 69 | 0.210 |
Why?
|
| Protein Isoforms | 4 | 2018 | 422 | 0.210 |
Why?
|
| Acetyl Coenzyme A | 1 | 2023 | 14 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4685 | 0.210 |
Why?
|
| Mammary Glands, Animal | 1 | 2007 | 453 | 0.210 |
Why?
|
| RNA, Antisense | 1 | 2023 | 36 | 0.210 |
Why?
|
| Lysosomes | 1 | 2025 | 261 | 0.200 |
Why?
|
| Apoptosis | 4 | 2021 | 1892 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2025 | 455 | 0.200 |
Why?
|
| Lipid Droplets | 2 | 2020 | 50 | 0.190 |
Why?
|
| Niacinamide | 2 | 2021 | 32 | 0.190 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2023 | 236 | 0.190 |
Why?
|
| HIV-1 | 1 | 2006 | 477 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2007 | 903 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2021 | 677 | 0.190 |
Why?
|
| Diet | 1 | 2009 | 1125 | 0.190 |
Why?
|
| Obesity | 8 | 2021 | 2395 | 0.190 |
Why?
|
| Ribosomes | 1 | 2023 | 125 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2020 | 161 | 0.190 |
Why?
|
| Drosophila Proteins | 6 | 1998 | 777 | 0.180 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 305 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1280 | 0.180 |
Why?
|
| Proto-Oncogenes | 3 | 1998 | 35 | 0.180 |
Why?
|
| Berberine | 1 | 2021 | 10 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2023 | 239 | 0.180 |
Why?
|
| Pyridinium Compounds | 1 | 2021 | 23 | 0.180 |
Why?
|
| Nanomedicine | 1 | 2021 | 26 | 0.180 |
Why?
|
| Liver Regeneration | 1 | 2021 | 39 | 0.170 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 34 | 0.170 |
Why?
|
| Carrier Proteins | 4 | 2005 | 1047 | 0.170 |
Why?
|
| Protein Stability | 2 | 2011 | 169 | 0.170 |
Why?
|
| Blotting, Western | 6 | 2015 | 1077 | 0.170 |
Why?
|
| Liver | 2 | 2022 | 1796 | 0.170 |
Why?
|
| Cardiolipins | 2 | 2018 | 19 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 2438 | 0.170 |
Why?
|
| Ubiquitination | 2 | 2011 | 172 | 0.170 |
Why?
|
| Exosomes | 1 | 2021 | 57 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2021 | 124 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 1997 | 232 | 0.170 |
Why?
|
| Symporters | 2 | 1998 | 77 | 0.170 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 21 | 0.170 |
Why?
|
| Male | 22 | 2025 | 64967 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 219 | 0.160 |
Why?
|
| Lipid Mobilization | 1 | 2020 | 2 | 0.160 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 27 | 0.160 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2020 | 15 | 0.160 |
Why?
|
| Dynamins | 1 | 2020 | 46 | 0.160 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 632 | 0.160 |
Why?
|
| Hexokinase | 1 | 2020 | 26 | 0.160 |
Why?
|
| Mitochondria, Heart | 2 | 2022 | 53 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 1826 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 90 | 0.160 |
Why?
|
| Female | 15 | 2025 | 70695 | 0.160 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2011 | 31 | 0.160 |
Why?
|
| RNAi Therapeutics | 1 | 2019 | 17 | 0.150 |
Why?
|
| Metronidazole | 1 | 2020 | 156 | 0.150 |
Why?
|
| Glucose | 2 | 2022 | 870 | 0.150 |
Why?
|
| RNA Stability | 1 | 2020 | 82 | 0.150 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 22 | 0.150 |
Why?
|
| Neutrophils | 1 | 2021 | 361 | 0.150 |
Why?
|
| NAD | 2 | 2009 | 52 | 0.150 |
Why?
|
| Cell Communication | 1 | 2020 | 187 | 0.150 |
Why?
|
| Amoxicillin | 1 | 2020 | 120 | 0.150 |
Why?
|
| Metaplasia | 1 | 2020 | 217 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 118 | 0.150 |
Why?
|
| Bone Diseases | 1 | 2019 | 46 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 220 | 0.150 |
Why?
|
| Lignans | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 38 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 56 | 0.140 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2018 | 16 | 0.140 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 127 | 0.140 |
Why?
|
| Fasting | 2 | 2009 | 302 | 0.140 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 20 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 327 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 379 | 0.130 |
Why?
|
| Leucine Zippers | 1 | 1997 | 18 | 0.130 |
Why?
|
| Thyroid Neoplasms | 6 | 1998 | 250 | 0.130 |
Why?
|
| Cell Movement | 1 | 2021 | 889 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2020 | 407 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 2005 | 1610 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 75 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 123 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 39 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 226 | 0.130 |
Why?
|
| Carcinoma, Papillary | 5 | 1998 | 93 | 0.130 |
Why?
|
| Rats | 7 | 2022 | 3609 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2018 | 375 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2020 | 1573 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 126 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 808 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2018 | 356 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2017 | 1608 | 0.120 |
Why?
|
| Lysine | 2 | 2017 | 185 | 0.120 |
Why?
|
| 3T3-L1 Cells | 2 | 2020 | 57 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 794 | 0.110 |
Why?
|
| Sex Characteristics | 3 | 2021 | 327 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 660 | 0.110 |
Why?
|
| Molecular Sequence Data | 8 | 2010 | 3770 | 0.110 |
Why?
|
| Computational Biology | 1 | 2020 | 875 | 0.110 |
Why?
|
| HIV Infections | 2 | 2006 | 2038 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 1995 | 144 | 0.110 |
Why?
|
| Ureaplasma urealyticum | 1 | 2014 | 2 | 0.110 |
Why?
|
| Ureaplasma Infections | 1 | 2014 | 9 | 0.110 |
Why?
|
| Progesterone | 1 | 2016 | 451 | 0.110 |
Why?
|
| Mice, Transgenic | 6 | 2022 | 2444 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 1284 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 1330 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 128 | 0.110 |
Why?
|
| Transfection | 4 | 2011 | 996 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 385 | 0.110 |
Why?
|
| Citrate (si)-Synthase | 2 | 2014 | 18 | 0.110 |
Why?
|
| Homeostasis | 4 | 2022 | 722 | 0.100 |
Why?
|
| Endometrium | 1 | 2016 | 277 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 540 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 263 | 0.100 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2013 | 55 | 0.100 |
Why?
|
| Insulin | 2 | 2012 | 1168 | 0.100 |
Why?
|
| Thyroid Gland | 5 | 1998 | 104 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 138 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1015 | 0.100 |
Why?
|
| Camptothecin | 1 | 2013 | 74 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 76 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1882 | 0.100 |
Why?
|
| Ion Channels | 3 | 2014 | 207 | 0.100 |
Why?
|
| Enzyme Activation | 3 | 2020 | 615 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 104 | 0.090 |
Why?
|
| Deoxyglucose | 1 | 2012 | 44 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 985 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 762 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 30 | 0.090 |
Why?
|
| RAW 264.7 Cells | 2 | 2024 | 46 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 111 | 0.090 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 341 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1659 | 0.090 |
Why?
|
| Half-Life | 1 | 2011 | 161 | 0.090 |
Why?
|
| Genomic Instability | 1 | 2013 | 245 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 238 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2009 | 38 | 0.090 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2014 | 211 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 459 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2009 | 98 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 90 | 0.080 |
Why?
|
| Gene Expression | 5 | 2000 | 1558 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2013 | 611 | 0.080 |
Why?
|
| Base Sequence | 5 | 2016 | 2899 | 0.080 |
Why?
|
| Succinate Dehydrogenase | 1 | 2010 | 8 | 0.080 |
Why?
|
| Prognosis | 1 | 2020 | 5014 | 0.080 |
Why?
|
| Animal Structures | 1 | 2009 | 15 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 734 | 0.080 |
Why?
|
| Models, Animal | 3 | 2019 | 469 | 0.080 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 73 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2009 | 44 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 369 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 60 | 0.080 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 21 | 0.070 |
Why?
|
| Longevity | 1 | 2010 | 160 | 0.070 |
Why?
|
| Isoproterenol | 1 | 2008 | 97 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2008 | 83 | 0.070 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 255 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 323 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 95 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ret | 6 | 1998 | 35 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2017 | 731 | 0.070 |
Why?
|
| Superoxides | 2 | 2021 | 133 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 291 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3037 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2007 | 43 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2009 | 224 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 672 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 76 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 436 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 601 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1997 | 230 | 0.060 |
Why?
|
| Receptors, HIV | 1 | 2006 | 3 | 0.060 |
Why?
|
| Body Weight | 1 | 2010 | 994 | 0.060 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 28 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 2669 | 0.060 |
Why?
|
| Methylation | 2 | 2019 | 207 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 1017 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 1998 | 1095 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2005 | 380 | 0.060 |
Why?
|
| Oncogenes | 2 | 1997 | 175 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2006 | 238 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1422 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2018 | 470 | 0.060 |
Why?
|
| Calreticulin | 1 | 2025 | 23 | 0.060 |
Why?
|
| Silicon Dioxide | 1 | 2025 | 30 | 0.060 |
Why?
|
| CD47 Antigen | 1 | 2025 | 11 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2005 | 24 | 0.060 |
Why?
|
| ADP Ribose Transferases | 1 | 2005 | 20 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 354 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 266 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 451 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 1697 | 0.050 |
Why?
|
| Temperature | 1 | 2005 | 302 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2006 | 433 | 0.050 |
Why?
|
| Brain | 2 | 2018 | 3176 | 0.050 |
Why?
|
| DNA Primers | 3 | 2010 | 636 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 201 | 0.050 |
Why?
|
| Glycosylation | 1 | 2023 | 126 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 664 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 488 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 1998 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 203 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 117 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 206 | 0.050 |
Why?
|
| Metallothionein | 1 | 2022 | 15 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2022 | 28 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 18 | 0.050 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2022 | 20 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 112 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2010 | 827 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 66 | 0.050 |
Why?
|
| Hormones, Ectopic | 1 | 2001 | 7 | 0.040 |
Why?
|
| Zinc | 1 | 2022 | 124 | 0.040 |
Why?
|
| Aged | 1 | 2020 | 21438 | 0.040 |
Why?
|
| DNA | 2 | 2005 | 1473 | 0.040 |
Why?
|
| RNA | 1 | 2005 | 552 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1410 | 0.040 |
Why?
|
| Tyrosine | 2 | 2001 | 150 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 275 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 81 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2020 | 66 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2000 | 122 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 126 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 241 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 1044 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 28998 | 0.040 |
Why?
|
| Thyrotropin | 2 | 1997 | 56 | 0.040 |
Why?
|
| Luciferases | 2 | 2013 | 129 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2019 | 11 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 55 | 0.040 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Carbon-Carbon Double Bond Isomerases | 1 | 2019 | 1 | 0.040 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2019 | 1 | 0.040 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2019 | 10 | 0.040 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 6 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 11 | 0.040 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Racemases and Epimerases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 42 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25786 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2022 | 360 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 52 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 67 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 663 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 31575 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 359 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2019 | 50 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 69 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 77 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2019 | 119 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 125 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 487 | 0.040 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 4 | 0.040 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 307 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 124 | 0.040 |
Why?
|
| Electron Transport | 1 | 2018 | 57 | 0.040 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2018 | 44 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2019 | 163 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 32 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 1995 | 136 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 38 | 0.030 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 1997 | 10 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2019 | 347 | 0.030 |
Why?
|
| PAX8 Transcription Factor | 1 | 1997 | 14 | 0.030 |
Why?
|
| Receptors, Thyrotropin | 1 | 1997 | 12 | 0.030 |
Why?
|
| Proteinuria | 1 | 2018 | 110 | 0.030 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 34 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 1997 | 75 | 0.030 |
Why?
|
| Phospholipids | 1 | 2018 | 104 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 95 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2019 | 331 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 94 | 0.030 |
Why?
|
| Thyroglobulin | 1 | 1997 | 7 | 0.030 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2017 | 9 | 0.030 |
Why?
|
| Myopia | 1 | 2018 | 133 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 196 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 301 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 308 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2017 | 31 | 0.030 |
Why?
|
| COS Cells | 1 | 1997 | 268 | 0.030 |
Why?
|
| Neuroprotection | 1 | 2017 | 31 | 0.030 |
Why?
|
| Dopaminergic Neurons | 1 | 2017 | 54 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 156 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 6228 | 0.030 |
Why?
|
| Body Height | 1 | 2017 | 204 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2010 | 1117 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 198 | 0.030 |
Why?
|
| Binding Sites | 3 | 2009 | 1256 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 296 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 71 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 350 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2017 | 233 | 0.030 |
Why?
|
| Stem Cells | 1 | 2000 | 732 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 472 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 611 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 235 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 28 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 147 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 596 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2016 | 231 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 98 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 263 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 442 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 575 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 176 | 0.030 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 374 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 2648 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7555 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 258 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1996 | 768 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 439 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1996 | 617 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2014 | 73 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 246 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 792 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 38 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 124 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 480 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 282 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1519 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 490 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 822 | 0.030 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 526 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 697 | 0.030 |
Why?
|
| Cattle | 2 | 2009 | 569 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 31 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2013 | 6 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2014 | 87 | 0.030 |
Why?
|
| Taurine | 1 | 1993 | 11 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 426 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 679 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2017 | 1121 | 0.020 |
Why?
|
| Introns | 2 | 2009 | 305 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 136 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 82 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 235 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 990 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2009 | 615 | 0.020 |
Why?
|
| Mitosis | 1 | 2013 | 196 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 164 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 1993 | 180 | 0.020 |
Why?
|
| Ghrelin | 1 | 2011 | 56 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 1799 | 0.020 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2010 | 19 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 420 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1548 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 1381 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 500 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 791 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2015 | 513 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 207 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 66 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 511 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 633 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 518 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 45 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2010 | 192 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 1182 | 0.020 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2009 | 10 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 110 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Eating | 1 | 2011 | 381 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2010 | 279 | 0.020 |
Why?
|
| Granulocytes | 1 | 2009 | 68 | 0.020 |
Why?
|
| Heart Failure | 1 | 2022 | 2393 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 763 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 348 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 367 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 361 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2011 | 785 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 846 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 800 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 252 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 337 | 0.010 |
Why?
|
| DNA, Neoplasm | 2 | 1996 | 295 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8549 | 0.010 |
Why?
|
| Benzophenones | 1 | 2001 | 6 | 0.010 |
Why?
|
| Resistin | 1 | 2001 | 30 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 25 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 100 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 3351 | 0.010 |
Why?
|
| Iodides | 1 | 1998 | 13 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 180 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 1998 | 3 | 0.010 |
Why?
|
| Receptor, EphB4 | 1 | 1998 | 3 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 28 | 0.010 |
Why?
|
| Receptors, Eph Family | 1 | 1998 | 22 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 148 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 1998 | 38 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1998 | 117 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 482 | 0.010 |
Why?
|
| Iodine | 1 | 1997 | 24 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1997 | 59 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 81 | 0.010 |
Why?
|
| Thyroxine | 1 | 1997 | 65 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 195 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 124 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 41 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1996 | 78 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 584 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1347 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 449 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 454 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 356 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1993 | 234 | 0.010 |
Why?
|
| Biological Transport | 1 | 1993 | 348 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 541 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 805 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 811 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 862 | 0.010 |
Why?
|
| Cell Division | 1 | 1993 | 743 | 0.010 |
Why?
|
| Time Factors | 1 | 1997 | 6448 | 0.000 |
Why?
|